Abivax presents first-half 2023 financial results finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Eastern Apples Deliver Sweet Sales - Produce Business producebusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from producebusiness.com Daily Mail and Mail on Sunday newspapers.
Abivax SA (Euronext Paris: FR0012333284 - ABVX) ("Abivax" or the "Company") today announced updated business and operational goals along with changes to Abivax's overall strategy , focused on preparing Abivax for the potential commercialization of its investigational lead asset, obefazimod, in IBD.